Could canakinumab be used for COVID-19?
Open Access
- 28 October 2020
- journal article
- Published by Publishing House OKI in Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice
- No. 4S,p. 50-52
- https://doi.org/10.37489/2588-0519-2020-s4-50-52
Abstract
Use of canakinumab in patients with COVID-19 is currently lacking proper evidence base, and should not be recommended outside of clinical trials.Keywords
This publication has 3 references indexed in Scilit:
- Correlation Analysis Between Disease Severity and Inflammation-related Parameters in Patients with COVID-19 PneumoniaPublished by Cold Spring Harbor Laboratory ,2020
- Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathologySeminars in Immunopathology, 2017
- Plasma inflammatory cytokines and chemokines in severe acute respiratory syndromeClinical and Experimental Immunology, 2004